Tuesday, June 30, 2020

FDA spells out guidelines for approving Covid-19 vaccines

The agency said development can be sped up through creative clinical trial designs that allow for scientists to adapt dosing and options based on rolling data. Those designs, known as adaptive or seamless trials, are fleshed out in the guidance. FDA said it will also be important to study vaccine candidates in patients with confirmed […]

from Newslanes https://ift.tt/3ggScVY

Related Posts:

0 comments:

Post a Comment